Global Clinical Leader
Daiichi Sankyo · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · Mallinckrodt
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Global Clinical Leader as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:09 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06772246 · A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart RateDaiichi Sankyo · completed · Healthy Subjects · study director
- Ph1NCT06740825 · Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy SubjectsDaiichi Sankyo · completed · Healthy Subjects · study director
- Ph1NCT06740799 · Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic ImpairmentDaiichi Sankyo · recruiting · Hepatic Impairment · study director
- Ph3NCT06578247 · Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AMLDaiichi Sankyo · active not recruiting · Leukemia · study director
- Ph1/Ph2NCT06362252 · A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)Daiichi Sankyo · recruiting · Extensive Stage-small Cell Lung Cancer · study director
- Ph1NCT06244485 · A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid TumorsDaiichi Sankyo · active not recruiting · Advanced Solid Tumor · study director
- Ph3NCT06174987 · A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)Daiichi Sankyo · recruiting · Advanced Cancer, Metastatic Cancer · study director
- Ph2NCT06172478 · A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsDaiichi Sankyo · recruiting · Advanced Solid Tumor, Melanoma, Head and Neck Cancer · study director
- Ph2/Ph3NCT06161025 · A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerDaiichi Sankyo · recruiting · Solid Cancer · study director
- Ph1/Ph2NCT05979831 · A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton SyndromeDaiichi Sankyo · terminated · Netherton Syndrome · study director
- Ph3NCT05950945 · Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerDaiichi Sankyo · recruiting · Breast Cancer · study director
- Ph1/Ph2NCT05875168 · First-in-Human Study of DS-3939a in Participants With Advanced Solid TumorsDaiichi Sankyo · recruiting · Advanced Solid Tumor, Metastatic Solid Tumor · study director
- N/ANCT05804747 · A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial FibrillationDaiichi Sankyo · completed · Atrial Fibrillation · study director
- N/ANCT05798390 · Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed DyslipidemiaDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · withdrawn · Primary Hypercholesterolemia, Mixed Dyslipidemia · study director
- Ph1NCT05765851 · A Study of DS-1103a Combination Therapy in Participants With Advanced Solid TumorsDaiichi Sankyo · recruiting · Advanced Solid Tumor · study director
- Ph1/Ph2NCT05638802 · A Study of DS-7011a in Patients With Systemic Lupus ErythematosusDaiichi Sankyo · completed · Systemic Lupus Erythematosus · study director
- Ph3NCT05555732 · Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)Daiichi Sankyo · active not recruiting · Metastatic Non Small Cell Lung Cancer · study director
- N/ANCT05458401 · EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab DeruxtecanDaiichi Sankyo · completed · HER2-positive Breast Cancer · study director
- Ph2NCT05280470 · Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)Daiichi Sankyo · active not recruiting · Extensive-stage Small-cell Lung Cancer · study director
- N/ANCT05262322 · Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial FibrillationDaiichi Sankyo UK Ltd, a Daiichi Sankyo Company · completed · Atrial Fibrillation · study director
- Ph3NCT05215340 · Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic AlterationsDaiichi Sankyo · active not recruiting · Metastatic Non Small Cell Lung Cancer · study director
- Ph1NCT05203692 · A Study of a Single Ascending Dose Study of DS-7011a in Healthy SubjectsDaiichi Sankyo · completed · Systemic Lupus Erythematosus · study director
- N/ANCT05120895 · An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of DyslipidemiaDaiichi Sankyo · completed · Dyslipidemia · study director
- N/ANCT05107063 · An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 DiabetesDaiichi Sankyo · completed · Dyslipidemia Associated With Type II Diabetes Mellitus · study director
- N/ANCT05025722 · Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE SiblingsDaiichi Sankyo · completed · Pseudoxanthoma Elasticum · study director
- Ph1/Ph2NCT04821674 · Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly SubjectsDaiichi Sankyo Co., Ltd. · completed · Covid19 · study director
- Ph1NCT04818398 · Study of Single-Ascending Doses of DS-6016a in Healthy Japanese SubjectsDaiichi Sankyo Co., Ltd. · completed · Fibrodysplasia Ossificans Progressiva · study director
- Ph1NCT04796831 · A Study to Determine the Absolute Oral Bioavailability of Quizartinib Using a Radiolabeled Microtracer in Healthy SubjectsDaiichi Sankyo · completed · Healthy Subjects · study director
- N/ANCT04747496 · Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in ChinaDaiichi Sankyo · completed · Non-valvular Atrial Fibrillation · study director
- Ph2NCT04744831 · Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal CancerDaiichi Sankyo · completed · Advanced Colorectal Cancer · study director
- Ph1NCT04707248 · A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian TumorsDaiichi Sankyo · active not recruiting · Renal Cell Carcinoma, Ovarian Tumor · study director
- Ph3NCT04704934 · Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)Daiichi Sankyo · active not recruiting · Gastric Cancer, Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma · study director
- Ph2NCT04703192 · Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)Daiichi Sankyo · active not recruiting · Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma · study director
- Ph2NCT04703322 · A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in JapanDaiichi Sankyo Co., Ltd. · completed · Tenosynovial Giant Cell Tumor · study director
- Ph1NCT04676477 · HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung CancerDaiichi Sankyo · active not recruiting · Non-Small Cell Lung Cancer (NSCLC) · study director
- Ph3NCT04656652 · Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)Daiichi Sankyo · active not recruiting · Non-small Cell Lung Cancer · study director
- Ph2NCT04644237 · Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)Daiichi Sankyo · completed · Non-Small Cell Lung Cancer · study director
- N/ANCT04635111 · A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) TreatmentDaiichi Sankyo · withdrawn · Hepatotoxicity, Tenosynovial Giant Cell Tumor · study director
- Ph3NCT04622319 · A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)Daiichi Sankyo · active not recruiting · HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer · study director
- N/ANCT04579367 · Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed DyslipidemiaDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · active not recruiting · Hypercholesterolemia, Mixed Dyslipidemia · study director
- Ph1NCT04526691 · Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)Daiichi Sankyo · active not recruiting · Advanced or Metastatic NSCLC · study director
- N/ANCT04519944 · Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary InterventionDaiichi Sankyo · completed · Non-valvular Atrial Fibrillation · study director
- Ph3NCT04488822 · A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCTDaiichi Sankyo Co., Ltd. · active not recruiting · Tenosynovial Giant Cell Tumor · study director
- Ph2NCT04484142 · Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)Daiichi Sankyo · completed · Non-small Cell Lung Cancer · study director
- Ph2NCT04479436 · A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal CancerDaiichi Sankyo · terminated · Metastatic Colorectal Cancer · study director
- Ph1NCT04473664 · A Study of Quizartinib Pharmacokinetics in Participants With Moderate Hepatic ImpairmentDaiichi Sankyo · completed · Hepatic Impairment, Moderate Impaired Hepatic Function · study director
- Ph1NCT04459598 · A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy ParticipantsDaiichi Sankyo Co., Ltd. · completed · Healthy Subjects, Drug-drug Interaction, Pharmacokinetics · study director
- Early Ph1NCT04459585 · A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy ParticipantsDaiichi Sankyo Co., Ltd. · completed · Healthy Subjects, Drug-drug Interaction, Pharmacokinetics · study director
- Ph1NCT04276415 · DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)Daiichi Sankyo · terminated · Gastrointestinal Stromal Tumors · study director
- Ph1NCT04276662 · Study of Single-dose DS-3201b in Participants With Hepatic ImpairmentDaiichi Sankyo · completed · Hepatic Impairment · study director
- Ph4NCT04169061 · Impact of Acthar on Everyday Life of Participants With Severe KeratitisMallinckrodt · completed · Keratitis · study director
- Ph1/Ph2NCT04145622 · Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant TumorsDaiichi Sankyo · active not recruiting · Advanced Solid Tumor, Malignant Solid Tumor · study director
- Ph1NCT04134143 · Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot UlcersStratatech, a Mallinckrodt Company · terminated · Diabetes, Diabetic Foot Ulcer, Non-healing Wound · study director
- Ph3NCT04123548 · StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT )Stratatech, a Mallinckrodt Company · completed · Deep Partial-thickness Burn · study director
- Ph1NCT04042701 · DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung CancerDaiichi Sankyo · active not recruiting · Breast Cancer, Non-small Cell Lung Carcinoma · study director
- Ph2NCT04014075 · DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)Daiichi Sankyo · completed · Adenocarcinoma Gastric Stage IV With Metastases, Adenocarcinoma - GEJ · study director
- Ph1NCT03901313 · Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy VolunteersDaiichi Sankyo · completed · Healthy Volunteers · study director
- Ph1/Ph2NCT03793478 · Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the BloodDaiichi Sankyo · active not recruiting · Acute Myeloid Leukemia · study director
- Ph3NCT03734029 · Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]Daiichi Sankyo · completed · Breast Cancer · study director
- Ph1NCT03723681 · Study of Quizartinib in Combination With Standard Therapies in Chinese Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)Daiichi Sankyo Co., Ltd. · completed · Acute Myeloid Leukemia (AML) · study director
- Ph2NCT03687476 · Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) DiseaseVtesse, LLC, a Mallinckrodt Pharmaceuticals Company · withdrawn · Niemann-Pick Disease, Type C · study director
- Early Ph1NCT03614455 · Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy ParticipantsDaiichi Sankyo · completed · Pharmacokinetics · study director
- Ph2NCT03384940 · DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)Daiichi Sankyo Co., Ltd. · completed · Colorectal Neoplasm · study director
- Ph1NCT03383692 · Study of DS-8201a for Participants With Advanced Solid Malignant TumorsDaiichi Sankyo Co., Ltd. · completed · Neoplasm Metastasis · study director
- Ph1NCT03368196 · DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) ProteinDaiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company · completed · Adenocarcinoma, Gastric, Neoplasm, Breast · study director
- Ph1NCT03366428 · Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast CancerDaiichi Sankyo Co., Ltd. · completed · Malignant Neoplasm of Breast · study director
- Ph2NCT03329690 · DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]Daiichi Sankyo Co., Ltd. · completed · Neoplasm, Gastrointestinal · study director
- Ph2NCT03316729 · DS-9231 in Intermediate-risk (Sub-massive) Acute Pulmonary Embolism (PE)Daiichi Sankyo · withdrawn · Pulmonary Embolism · study director
- Ph1NCT03305471 · DS2330b Alone and With Sevelamer in Patients on Chronic HemodialysisDaiichi Sankyo · completed · Hyperphosphatemia · study director
- Ph1NCT03291288 · Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)Daiichi Sankyo · completed · Drug Interaction Potential · study chair
- Ph1NCT03255083 · DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung CancerDaiichi Sankyo · terminated · Non-small Cell Lung Cancer (NSCLC) · study director
- Ph2NCT03248492 · A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)Daiichi Sankyo · terminated · Breast Cancer · study director
- N/ANCT03198715 · Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With ThrombectomyDaiichi Sankyo Co., Ltd. · completed · Acute Ischemic Stroke · study director
- Ph1NCT03110354 · DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)Daiichi Sankyo · terminated · Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute · study director
- Ph3NCT03097861 · Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to PlaceboSucampo Pharma Americas, LLC · completed · Chronic Idiopathic Constipation · study director
- Ph1NCT03030066 · Study of DS-1001b in Patients With Gene IDH1-Mutated GliomasDaiichi Sankyo · completed · Glioma · study director
- Ph3NCT03010631 · Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy VolunteersSucampo Pharma Americas, LLC · completed · Healthy Volunteers · study director
- Ph2NCT02984995 · Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) MutationDaiichi Sankyo Co., Ltd. · completed · Leukemia, Myeloid, Acute · study director
- Ph1/Ph2NCT02980341 · Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast CancerDaiichi Sankyo Co., Ltd. · completed · Metastatic Breast Cancer · study director
- N/ANCT02975700 · A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated MelanomaDaiichi Sankyo Co., Ltd. · completed · Melanoma · study director
- N/ANCT02964949 · Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical OutcomesDaiichi Sankyo · completed · Atrial Fibrillation · study director
- Ph4NCT02953821 · Acthar Gel for Active Systemic Lupus Erythematosus (SLE)Mallinckrodt · completed · Lupus Erythematosus, Systemic · study director
- N/ANCT02952599 · Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)Daiichi Sankyo · completed · Venous Thromboembolism · study director
- N/ANCT02951039 · Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Korea and Taiwan (ETNA-AF-KOR-TWN)Daiichi Sankyo · completed · Atrial Fibrillation · study director
- N/ANCT02950168 · Edoxaban Management in Diagnostic and Therapeutic ProceduresDaiichi Sankyo · completed · Atrial Fibrillation, Venous Thromboembolism · study director
- N/ANCT02948088 · Tenosynovial Giant Cell Tumors (TGCT) Observational Platform ProjectDaiichi Sankyo · completed · Giant Cell Tumors · study director
- Ph3NCT02943785 · Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)Daiichi Sankyo · completed · Atrial Fibrillation · study director
- N/ANCT02944019 · Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial FibrillationDaiichi Sankyo · completed · Atrial Fibrillation · study director
- N/ANCT02943993 · Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in EuropeDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · completed · Venous Thromboembolism · study director
- Ph3NCT02942576 · Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter AblationDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · completed · Atrial Fibrillation · study director
- Ph3NCT02890173 · Study of CS-3150 in Patients With Essential HypertensionDaiichi Sankyo Co., Ltd. · completed · Essential Hypertension · study director
- N/ANCT02885662 · Study of CS-3150 in Patients With Primary AldosteronismDaiichi Sankyo Co., Ltd. · completed · Primary Aldosteronism · study director
- N/ANCT02848170 · Study of CS-3150 Compared to Olmesartan in Patients With Essential HypertensionDaiichi Sankyo Co., Ltd. · completed · Essential Hypertension · study director
- Ph4NCT02848729 · Drug Interactions Between Morphine and Orally or IV Administered AcetaminophenMallinckrodt · completed · Pain · study director
- Ph1NCT02834390 · Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)Daiichi Sankyo Co., Ltd. · completed · Acute Myeloid Leukemia · study director
- Ph3NCT02807987 · Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal ImpairmentDaiichi Sankyo Co., Ltd. · completed · Hypertension With Moderate Renal Impairment · study director
- Ph3NCT02801669 · Study of DU-176b Aged 80 Years or OlderDaiichi Sankyo Co., Ltd. · completed · Atrial Fibrillation · study director
- Ph3NCT02798471 · Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)Daiichi Sankyo · completed · Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT) · study director
- Ph1NCT02734433 · Study of Pexidartinib in Asian Subjects With Advanced Solid TumorsDaiichi Sankyo Co., Ltd. · completed · Advanced Solid Tumors · study director
- Ph1NCT02732275 · DS-3201b in Participants With LymphomasDaiichi Sankyo Co., Ltd. · active not recruiting · Lymphoma, Malignant, Non-hodgkin Lymphoma · study director
- Ph3NCT02722265 · Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential HypertensionDaiichi Sankyo Co., Ltd. · completed · Essential Hypertension · study director
- Ph1NCT02690337 · Study of DS-1123a in Advanced Solid TumoursDaiichi Sankyo Co., Ltd. · completed · Advanced Solid Malignant Tumors · study director
- Ph3NCT02685137 · Efficacy and Safety of Stannsoporfin in NeonatesInfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · completed · Nutritional and Metabolic Diseases · study director
- Ph4NCT02678416 · Reduction in Pain Intensity Following IV or Oral Pain-relieving ProductsMallinckrodt · completed · Pain · study director
- Ph1NCT02675491 · Phase 1 Study of DS-6051b in Japanese Subjects With Advanced Solid Malignant TumorsDaiichi Sankyo Co., Ltd. · completed · Advanced Solid Malignant Tumors · study director
- Ph3NCT02668653 · Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)Daiichi Sankyo · completed · Acute Myeloid Leukemia, Leukemia · study director
- Ph1/Ph2NCT02667483 · Study of DS-5141b in Patients With Duchenne Muscular DystrophyDaiichi Sankyo Co., Ltd. · completed · Duchenne Muscular Dystrophy · study director
- Ph1NCT02657876 · ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot UlcersStratatech, a Mallinckrodt Company · completed · Diabetes, Diabetic Foot Ulcer, Non-healing Wound · study director
- Ph1/Ph2NCT02586233 · Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic StrokeDaiichi Sankyo · completed · Acute Ischemic Stroke, Thrombotic Disease · study director
- Ph1NCT02564861 · Multiple Dose Study of D1971a in Healthy VolunteersDaiichi Sankyo · completed · Healthy · study director
- Ph1NCT02564900 · Study of DS-8201a in Subjects With Advanced Solid Malignant TumorsDaiichi Sankyo Co., Ltd. · completed · Advanced Solid Tumors · study director
- Ph2NCT02544152 · Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel SyndromeSucampo Pharma Americas, LLC · terminated · Irritable Bowel Syndrome · study director
- Ph2NCT02542215 · Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and ChemotherapySucampo Pharma Americas, LLC · terminated · Oral Mucositis · study director
- Ph1NCT02530918 · Study of DS-7080a for the Treatment of Macular DegenerationDaiichi Sankyo · completed · Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema · study director
- Ph4NCT02508935 · Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute PainMallinckrodt · terminated · Acute Pain · study director
- Ph3NCT02496884 · Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney DiseaseDaiichi Sankyo · completed · Fibromyalgia · study director
- Ph1NCT02319369 · Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)Daiichi Sankyo · terminated · Acute Myelogenous Leukemia, Myelodysplastic Syndrome · study director
- N/ANCT02318719 · DS-5565 Phase III Study for Post-herpetic NeuralgiaDaiichi Sankyo Co., Ltd. · completed · Post-Herpetic Neuralgia · study director
- Ph3NCT02318706 · DS-5565 Phase III Study for Diabetic Peripheral Neuropathic PainDaiichi Sankyo Co., Ltd. · completed · Diabetic Peripheral Neuropathic Pain · study director
- Ph1NCT02303431 · Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) StudyDaiichi Sankyo · completed · Deep Vein Thrombosis, Venous Thromboembolism · study director
- Ph3NCT02234583 · An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With FibromyalgiaDaiichi Sankyo · completed · Pain Associated With Fibromyalgia · study director
- Ph3NCT02187471 · Treatment of Pain Associated With FibromyalgiaDaiichi Sankyo · completed · Pain Associated With Fibromyalgia · study director
- Ph3NCT02187159 · Treatment of Pain Associated With FibromyalgiaDaiichi Sankyo · completed · Pain Associated With Fibromyalgia · study director
- Ph3NCT02146430 · Treatment of Pain Associated With FibromyalgiaDaiichi Sankyo · completed · Pain Associated With Fibromyalgia · study director
- Ph3NCT02138136 · Lubiprostone for Children With ConstipationSucampo Pharma Americas, LLC · completed · Constipation - Functional · study director
- Ph3NCT02134015 · Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)Daiichi Sankyo · terminated · Lung Cancer, Non-small Cell Lung Cancer · study director
- Ph2NCT02117349 · Topical Raplixa for Surgical Bleeding in ChildrenMallinckrodt · terminated · Surgical Bleeding · study director
- Ph3NCT02073682 · Cancer Venous Thromboembolism (VTE)Daiichi Sankyo · completed · Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) · study director
- Ph3NCT02072434 · Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)Daiichi Sankyo · completed · Atrial Fibrillation · study director
- Ph3NCT02039726 · (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD PositiveDaiichi Sankyo · completed · AML · study director
- N/ANCT02000830 · Follow up Study of Patients Having Participated in Clinical Trial 64,185-204InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · completed · Hyperbilirubinemia, Neonatal · study chair
- Ph3NCT01993875 · Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic ConstipationMallinckrodt · completed · Chronic Idiopathic Constipation · study director
- Ph2NCT01887327 · Stannsoporfin With Light Therapy for Newborn Babies With JaundiceInfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · completed · Jaundice, Neonatal, Hyperbilirubinemia, Neonatal · study director
- Ph1NCT01877382 · A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or LymphomasDaiichi Sankyo · completed · Advanced Solid Tumor, Lymphoma · study director
- Ph2NCT01802775 · Edoxaban in Peripheral Arterial DiseaseDaiichi Sankyo · completed · Peripheral Arterial Disease · study director
- Ph1/Ph2NCT01790503 · A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed GlioblastomaDaiichi Sankyo · completed · Patients With Newly Diagnosed Glioblastoma · study director
- Ph2NCT01756898 · Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic DermatitisDaiichi Sankyo · completed · Atopic Dermatitis · study director
- Ph3NCT01755767 · Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior TherapyDaiichi Sankyo · completed · Hepatocellular Carcinoma · study director
- Ph4NCT01753401 · Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active DiseaseMallinckrodt · completed · Systemic Lupus Erythematosus (SLE) · study director
- Ph1NCT01747135 · Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 DiseaseVtesse, LLC, a Mallinckrodt Pharmaceuticals Company · completed · Niemann-Pick Disease, Type C1 · study director
- N/ANCT01634230 · Emergency Use of OCR-002 in Acute Liver Failure (ALF)Ocera Therapeutics, Inc. · no longer available · Acute Liver Failure · study director
- Ph2NCT01565668 · Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid LeukemiaDaiichi Sankyo · completed · Leukemia, Myeloid, Acute · study director
- Ph3NCT01527357 · A Study of Fibrocaps™ in Surgical BleedingMallinckrodt · completed · Mild or Moderate Surgical Bleeding · study director
- Ph1/Ph2NCT01512199 · Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)Daiichi Sankyo · terminated · Metastatic Breast Cancer · study director
- Ph2NCT01502631 · Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)Daiichi Sankyo · completed · Acute Spinal Cord Injury · study director
- N/ANCT01496885 · Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic StrokeDaiichi Sankyo · completed · Nonhemorrhagic Ischemic Stroke, Motor Function · study director
- Ph4NCT01386554 · Acthar for Treatment of Proteinuria in Membranous Nephropathy PatientsMallinckrodt · completed · Proteinuria, Idiopathic Membranous Nephropathy · study director
- Early Ph1NCT01380535 · Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)Mallinckrodt · completed · Chronic Graft Versus Host Disease · study director
- Ph1NCT01288430 · A Study of DS-2248 in Participants With Advanced Solid TumorsDaiichi Sankyo · terminated · Solid Tumors, Non-small Cell Lung Carcinoma · study director
- Ph4NCT01258075 · Colesevelam for Children With Type 2 DiabetesDaiichi Sankyo · completed · Type 2 Diabetes Mellitus · study director
- Ph3NCT01244191 · Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung CancerDaiichi Sankyo · terminated · Non Squamous, Non-small-cell Lung Cancer · study director
- Ph1/Ph2NCT01211483 · Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung CancerDaiichi Sankyo · completed · NSCLC (Advanced Non-small Cell Lung Cancer) · study director
- Ph1NCT01199068 · CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)Daiichi Sankyo Co., Ltd. · completed · Carcinoma, Non-Small-Cell Lung · study director
- Ph1NCT01199055 · CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)Daiichi Sankyo Co., Ltd. · completed · Carcinoma, Non-Small-Cell Lung · study director
- Ph2NCT01101334 · Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung CancerDaiichi Sankyo · completed · Advanced Non-small Cell Lung Cancer (NSCLC) · study director
- Ph2NCT01033240 · CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver CancerDaiichi Sankyo · completed · Advanced Hepatocellular Carcinoma, Liver Cancer, Hepatic Cancer · study director
- Ph2NCT00986440 · Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line ChemotherapyDaiichi Sankyo · terminated · Colorectal Cancer · study director
- Ph2NCT00945191 · Combination Chemotherapy With CS-1008 to Treat Ovarian CancerDaiichi Sankyo · completed · Ovarian Cancer Stage IIIC, Ovarian Cancer Stage IV · study director
- Ph2NCT00806286 · Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung CancerDaiichi Sankyo · completed · Metastatic Non-small Cell Lung Cancer · study director
- Ph3NCT00789750 · Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes MellitusDaiichi Sankyo · completed · Type 2 Diabetes Mellitus · study director
- Ph2NCT00717769 · A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic DermatitisDaiichi Sankyo · completed · Atopic Dermatitis · study director
- Ph2NCT00698828 · SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)Daiichi Sankyo · completed · Cachexia · study director
- Ph3NCT00626028 · Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator TestingMallinckrodt · completed · Idiopathic Pulmonary Arterial Hypertension, Cardiomyopathy · study director
- Ph2NCT00623363 · Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's DiseaseDaiichi Sankyo · completed · Parkinson's Disease · study director
- Ph3NCT00620061 · Opioid-induced Bowel Dysfunction: Long-Term Assessment of LubiprostoneSucampo Pharma Americas, LLC · completed · Opioid-Induced Bowel Dysfunction · study director
- Ph2NCT00597818 · Cobiprostone Prevention of NSAID-induced Gastroduodenal InjurySucampo Pharma Americas, LLC · completed · NSAID-induced Gastroduodenal Injury, Ulcers, Rheumatoid Arthritis · study director
- Ph3NCT00571519 · Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes MellitusDaiichi Sankyo · terminated · Type 2 Diabetes Mellitus · study director
- Ph2NCT00521404 · Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic CancerDaiichi Sankyo · completed · Pancreatic Cancer · study director
- Ph3NCT00484198 · Study of Rivoglitazone in Type 2 Diabetes MellitusDaiichi Sankyo · completed · Type 2 Diabetes Mellitus · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Clinical Trial of Antimicrobial Skin to treat Diabetic UlcersR44DK069924 · NIDDK · STRATATECH CORPORATION · PI Allen R. Comer, Mary A. Lokuta · fiscal years 2004 to 2013Named on NCT02657876
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.